Why is evidence-based medicine so harsh on vaccines? An exploration of the method and its natural biases

Vaccine

Volumn 25, Issue 16 SPEC. ISS., 2007, Pages 3165-3169

  Jacobson, Robert M ^a   Targonski, Paul V ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Evidence based medicine; Vaccination; Vaccines

Indexed keywords

HEPATITIS A VACCINE; INFLUENZA VACCINE;

ARTICLE; EVIDENCE BASED MEDICINE; HEALTH CARE PERSONNEL; HEPATITIS A; HUMAN; INFLUENZA; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; VACCINATION;

EID: 33947578644     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.01.049     Document Type: Article

References (25)

1. Anonymous, and Evidence-Based Medicine Working Group. Evidence-based medicine. A new approach to teaching the practice of medicine. JAMA 268 17 (1992) 2420-2425
2. Cochrane A. Effectiveness and efficiency: random reflections on health services (1972), Nuffield Provincial Hospitals Trust, London
3. Grimshaw J. So what has the Cochrane Collaboration ever done for us? A report card on the first 10 years. CMAJ Can Med Assoc J 171 7 (2004) 747-749
4. CDC. Impact of vaccines universally recommended for children--United States, 1990-1998. MMWR 48 (1999) 243-248
5. CDC. Ten great public health achievements--United States, 1900-1999. MMWR 48 (1999) 241-243
6. Advisory Committee on Immunization. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 55 RR-10 (2006) 1-42
7. Thomas R.E., Jefferson T., Demicheli V., and Rivetti D. Influenza vaccination for healthcare workers who work with the elderly. Cochrane Database Syst Rev 3 (2006) CD005187
8. Smith S., Demicheli V., Di Pietrantonj C., et al. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 1 (2006) CD004879
9. In: Stratton K., Gable A., and Shetty P. (Eds). Immunization safety review: measles-mumps-rubella vaccine and autism (2001), National Academy Press, Washington, D.C.
10. American Academy of Pediatrics. Section 1. Active and passive immunization. In: Pickering L., Baker C., Long S., and McMillan J. (Eds). Red book: 2006 report of the committee on infectious diseases. 27th ed. vol. 2006 (2006), American Academy of Pediatrics, Elk Grove Village, IL
11. Demicheli V., Jefferson T., Rivetti A., and Price D. Vaccines for measles, mumps and rubella in children. Cochrane Database Syst Rev 4 (2005) CD004407
12. Watson L., Wilson B.J., and Waugh N. Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults. Vaccine 20 17-18 (2002) 2166-2173
13. Poirier M.K., Poland G.A., and Jacobson R.M. Parameters potentially affecting interpretation of immunogenicity and efficacy data in vaccine trials: are they adequately reported?. Vaccine 14 1 (1996) 25-27
14. Roberts R., Rodriguez W., Murphy D., and Crescenzi T. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA 290 7 (2003) 905-911
15. Committee on Clinical Research Involving Children & Medicine, I.o. The ethical conduct of clinical research involving children (2004), National Academies Press, Washington, D.C
16. Walson P.D. Patient recruitment: US perspective. Pediatrics 104 3 Pt 2 (1999) 619-622
17. Advisory Committee on Immunization Practices. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 55 RR-7 (2006) 1-23
18. Broder K.R., Cortese M.M., Iskander J.K., et al. Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep Recomm Rep 55 RR-3 (2006) 1-34
19. Advisory Committee on Immunization Practices. ACIP provisional recommendations for the use of quadrivalent HPV vaccine vol. 2006 (2006), Centers for Disease Control and Prevention
20. Lau J., Ioannidis J.P., and Schmid C.H. Summing up evidence: one answer is not always enough. Lancet 351 9096 (1998) 123-127
21. Fedson D.S., and Nichol K.L. Influenza vaccination: policy versus evidence - no gap between policy and evidence. Br Med J 333 7576 (2006) 1020
22. Ward J., Broome C., Harrison L., Shinefield H., and Black S. Haemophilus influenzae type b vaccines: lessons for the future. Pediatrics 81 (1988) 886-893
23. Centers for Disease Control & Prevention. Intussusception among recipients of rotavirus vaccine--United States, 1998-1999. MMWR Morb Mortal Wkly Rep 48 27 (1999) 577-581
24. Jacobson R.M., Adegbenro A., Pankratz V.S., and Poland G.A. Adverse events and vaccination-the lack of power and predictability of infrequent events in pre-licensure study. Vaccine 19 17-19 (2001) 2428-2433
25. Clements C.J. The evidence for the safety of thiomersal in newborn and infant vaccines. Vaccine 22 15-16 (2004) 1854-1861